-
Hedge Fund and Insider Trading News: Kyle Bass, Daniel Och, Bill Ackman, Perceptive Advisors, Schonfeld Strategic Advisors, Coatue Management, Merrimack Pharmaceuticals Inc (MACK), AMC Entertainment Holdings Inc (AMC), and More
14 Jan 2022 19:43 GMT
Hedge Fund Manager Kyle Bass: Buckle Your Seatbelts on Oil Prices (Seeking Alpha)
Closely watched hedge fund manager Kyle Bass said Thursday that oil prices could rise “well north of $100” in 2022 as a lack of investment in the hydrocarbon industry meets a …
-
Elevation Oncology Files for $100M IPO
07 Jun 2021 19:06 GMT
… raise $100 million in an IPO. See SEC prospectus here.
Proceeds … that failed multiple trials at Merrimack Pharmaceuticals Inc (NASDAQ: MACK) before being …
-
The Daily Biotech Pulse: European Regulatory Nod For Xeris, Amicus Falls On Data, 4 IPOs, FDA Decision For Mallinckrodt's StrataGraft Delayed
12 Feb 2021 15:46 GMT
… , Inc. (NASDAQ: MMSI)
Merrimack Pharmaceuticals Inc (NASDAQ: MACK)
Monopar … FDA Decision, Earnings, IPOs and Conference Presentations In … , priced its downsized initial public offering of 2.66 million … Decibel Therapeutics priced its IPO of 7.062 million …
-
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
12 Mar 2020 12:09 GMT
… )
Meridian Bioscience, Inc. (NASDAQ: VIVO)
Merrimack Pharmaceuticals Inc (NASDAQ: MACK)
Misonix Inc … close)
• Synlogic (after the close)
IPOs
Imara, a biopharma company that … rare hemoglobinopathies, priced its upsized IPO of 4.70 million shares …
-
The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO
28 Feb 2020 12:42 GMT
… )
Menlo Therapeutics Inc (NASDAQ: MNLO)
Merrimack Pharmaceuticals Inc (NASDAQ: MACK)
Midatech Pharma … : GLYC) (before the market open)
IPO
Passage Bio, a biotech developing …
-
Abpro's IPO: Promising Team, But At An Early Stage
08 May 2018 13:21 GMT
… capital through a new IPO. According to the Nasdaq … time before executing the initial public offering. What are the consequences … head of translational medicine at Merrimack Pharmaceuticals (NASDAQ: MACK), lecturer … market will treat new IPOs in the next two …
-
The Week Ahead In Biotech: PDUFA Dates, Earnings, IPOs And More
07 May 2018 00:46 GMT
… )
Melinta Therapeutics, Inc. (NASDAQ: MLNT)
Merrimack Pharmaceuticals Inc (NASDAQ: MAC)
Momenta Pharmaceuticals … )
Fibrocell Science Inc (NASDAQ: FCSC)
IPO
Immuno-oncology company Abpro is …
-
12 Best Performing Biotech Stocks in 2022
29 Dec 2022 03:49 GMT
… in biotech startups, IPOs, and financing innovation … with these firms. 12. Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) … December 28: 163.73% Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK … , Inc. (NASDAQ:NVAX), Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) …